$DPLO News
Last published 5y ago
- 5y agoZOMDPLOSean Whelan Appointed to Board of DirectorsGlobeNewswireANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to it
- 6y agoDPLOUNHCVSMHSDaniel Davison Joins Advanced Dermatology and Cosmetic Surgery as Chief Financial OfficerBusiness WireMAITLAND, Fla.--(BUSINESS WIRE)--Advanced Dermatology and Cosmetic Surgery (ADCS), one of the nation’s leaders in high-quality dermatology, today announced the appointment of Daniel Davison as Chief Financial Officer.
- 6y agoDPLOUNHANTMESI+1Advanced Dermatology and Cosmetic Surgery Announces the Appointment of Brian T. Griffin as Chief Executive OfficerBusiness WireMAITLAND, Fla.--(BUSINESS WIRE)--Advanced Dermatology and Cosmetic Surgery (ADCS), a national leader in dermatology care, today announced that Brian T. Griffin has been appointed as Chief Executive Officer.
- 6y agoGNRCALEXDPLOUNH+3Generac Holdings Set to Join S&P MidCap 400; Alexander & Baldwin and America's Car-Mart to Join S&P SmallCap 600PR NewswireS&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday,...
- 6y agoWBACPSTRADDPLOInnovation Introduces New Leadership Team to IndustryPR NewswireInnovation, the market-leading provider of high-volume pharmacy automation technology and software solutions to the retail, hospital, federal health...
- 7y agoDPLODiplomat Announces 3rd Quarter Financial Results; Updates 2019 GuidancePR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial...
- 7y agoDPLODiplomat to Release Third-Quarter 2019 Operating Results Nov. 12PR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO) will release its third-quarter 2019 operating results before market open Tuesday, Nov. 12. A conference call and ...
- 7y agoDPLODiplomat Announces Sale of Certain Assets of Envoy Health Management, LLC to Diligent Health Solutions, LLCPR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO), effective today, has completed the sale of certain assets of Envoy Health Management, LLC to Diligent Health...
- 7y agoDPLODiplomat Announces Promotion of David Skomo to Chief Operating Officer of CastiaRxPR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO), has appointed David Skomo as chief operating officer of CastiaRx following the retirement of Chris Luthin....
- 7y agoDPLODiplomat Pharmacy's (DPLO) CEO Brian Griffin on Q2 2019 Results - Earnings Call TranscriptEarnings Call Transcripts
- 7y agoDPLODiplomat Announces 2nd Quarter Financial Results; Updates 2019 GuidancePR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial...
- 7y agoDPLODiplomat Announces Review of Strategic AlternativesPR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its Board of Directors is reviewing strategic alternatives. At the direction of its Board...
- 7y agoDPLODiplomat signs exclusive practice-based infusion agreement with Allergy PartnersPR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO), is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office...
- 7y agoDPLODiplomat to Release Second-Quarter 2019 Operating Results August 9PR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO), will release its second-quarter 2019 operating results before market open Friday, August 9. A conference call...
- 7y agoDPLODiplomat Launches Empower Ecosystem Patient Support Digital LibraryPR NewswireDiplomat Pharmacy, Inc. (NYSE: DPLO), announced the launch of EMPOWER ECOSYSTEM, an online collection of services and tools to help patients and...
- 8y agoDPLODiplomat Pharmacy, Inc. (DPLO) CEO Brian Griffin on Q2 2018 Results - Earnings Call TranscriptEarnings Call Transcripts
- 8y agoDPLODiplomat Pharmacy's (DPLO) Interim CEO Jeff Park on Q1 2018 Results - Earnings Call TranscriptEarnings Call Transcripts
- 8y agoDPLODiplomat Pharmacy's (DPLO) CEO Jeff Park on Q4 2017 Results - Earnings Call TranscriptEarnings Call Transcripts
- 8y agoDPLODiplomat Pharmacy, Inc.'s (DPLO) CEO Phil Hagerman on Acquisition of LDI Integrated Pharmacy Services Conference Call - (Transcript)Earnings Call Transcripts
- 9y agoDPLODiplomat Pharmacy's (DPLO) CEO Philip Hagerman on Q1 2017 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoDPLOIMPORTANT EQUITY ALERT: Lundin Law PC Announces an Investigation of Diplomat Pharmacy, Inc. and Advises Investors with Losses to Contact the FirmBusiness WireLOS ANGELES--(BUSINESS WIRE)--Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE: DPLO) concerning possible violations of federal securities laws.
- 10y agoDPLODiplomat Pharmacy's (DPLO) Management Presents at Robert W. Baird 2016 Healthcare Conference (Transcript)Earnings Call Transcripts
- 10y agoDPLODiplomat's (DPLO) CEO Phil Hagerman on Q1 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoDPLODiplomat Pharmacy's (DPLO) CEO Phil Hagerman on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts
- 11y agoDPLOGEGE Capital Provides $320 Million Credit Facility to Diplomat Pharmacy, Includes Funds for Acquisition of BioRxBusiness WireBETHESDA, Md.--(BUSINESS WIRE)--GE Capital’s Healthcare Financial Services (HFS) business announced today that it has provided a $320 million senior secured credit facility to Diplomat Pharmacy, Inc., the country’s largest independent specialty pharmacy. GE Capital Markets was lead arranger and bookrunner on the transaction.
- 11y agoBIOLINFUDPLOBIOLASE Names David C. Dreyer Chief Financial OfficerBusiness WireIRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it has hired veteran financial executive David C. Dreyer as its Chief Financial Officer. He will report to BIOLASE President and CEO Jeffrey M. Nugent and join the Company, effective March 9. Mr. Dreyer replaces Frederick D. Furry, who resigned January 31 to pursue other opportuni ...